MCK Stock Up on Q4 Earnings Beat & Potential Surgical Biz Spin-Off

McKesson Corporation (MCK) reported fourth-quarter fiscal 2025 adjusted earnings per share (EPS) of $10.12, which beat the Zacks Consensus Estimate of $9.81 by 3.2%. The bottom line, however, improved 63.8% on a year-over-year basis. The robust EPS growth was driven by solid top-line improvement on the back of strength in core pharmaceutical distribution business, expansion of the Oncology platform and continued growth of differentiated biopharma solutions.GAAP EPS was $10.01, up 66.3% from the year-ago qua ...